HPA-Global member Niagen Bioscience announced that Chief Executive Officer Rob Fried and Chief Financial Officer Ozan Pamir will participate in Canaccord Genuity’s Well Summit, taking place September 28–30, 2026, in New York City.
Fried is scheduled to participate in the panel “Aging on Trial: Peptides, Hormones, and the Line Between Breakthrough and Hype” on September 29 from 11:15 a.m. to 12:00 p.m. Eastern Time at The Plaza in New York.
The Well Summit, now in its second year, brings together executives, investors and innovators working across the consumer health and wellness sector. Niagen said a replay of Fried’s panel discussion will subsequently be available through the company’s investor relations website.
Niagen Bioscience focuses on NAD+ and healthy-aging science. Its portfolio centers on Niagen®, the company’s patented nicotinamide riboside (NR) ingredient, which is used in its Tru Niagen® consumer supplement line and other applications.
What this means for the dietary supplement industry
Healthy aging and longevity continue to move toward the center of the broader health and wellness conversation. The inclusion of topics such as NAD+, peptides, hormones and aging interventions at an investor-oriented health summit illustrates the growing commercial and scientific attention being directed toward the category.
For the dietary supplement industry, this also increases the importance of distinguishing products and ingredients through credible research, substantiated claims and clearly communicated science as consumers become increasingly interested in longevity and healthspan.
Source: Niagen Bioscience & HPA-Global
Original Niagen Bioscience announcement
If your company is active in the dietary supplement, functional food, ingredient, or health products industry and is not yet a member of HPA-Global, we invite you to consider joining the association. HPA-Global supports members with China and global market intelligence, marketing visibility, industry connections, and access to regulatory support for supplements, ingredients, and related health products in China, the EU, Japan, South Korea, and the U.S. For companies looking to expand internationally and stay ahead of market and regulatory changes, HPA-Global offers one of the best values in the industry. Contact us for more details: info@hpaglobal.org.